Since announcing his candidacy for President of the United States, Vivek Ramaswamy has branded himself as a fierce China hawk, going as far as to declare that he would ban American companies from doing business with the Chinese government.
But not so long ago, Mr Ramaswamy was singing a very different tune.
The career biopharma boss has made a hasty 180 degree turn away from his pro-China advocacy and corporate fundraising in recent years.
The Dossier reviewed Vivek Ramaswamy’s business ties in China and found that he aggressively sought to partner with the Chinese government on multiple endeavors throughout the country.
It began in 2017. As the CEO and founder of the biotech company Roivant, Ramaswamy partnered with the CIVIC Group, the state-run investment company of the Chinese government, to form a corporation called Sinovant, which would serve as Roivant’s Chinese (Sino means Chinese or relating to China) “vant” arm.
Hellbound and Down 